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Expression of the src-family kinase
lymphocyte-specific protein tyrosine kinase
(Lck) at the plasma membrane is essen-
tial for it to fulfill its pivotal role in signal
transduction in T lymphocytes. MAL, an
integral membrane protein expressed in
specific types of lymphoma, has been
shown to play an important role in target-
ing Lck to the plasma membrane. Here we
report that MAL interacts with Inverted
Formin2 (INF2), a formin with the atypical
property of promoting not only actin poly-
merization but also its depolymerization.
In Jurkat T cells, INF2 colocalizes with
MAL at the cell periphery and pericentrio-
lar endosomes and along microtubules.
Videomicroscopic analysis revealed that
the MAL vesicles transporting Lck to the
plasma membrane move along microtu-
bule tracks. Knockdown of INF2 greatly
reduced the formation of MAL transport
vesicles and the levels of Lck at the
plasma membrane and impaired forma-
tion of a normal immunologic synapse.
The actin polymerization and depolymer-
ization activities of INF2 were both re-
quired for efficient Lck targeting. Cdc42
and Rac1, which bind to INF2, regulate
Lck transport in both Jurkat and primary
human T cells. Thus, INF2 collaborates
with MAL in the formation of specific
carriers for targeting Lck to the plasma
membrane in a process regulated by
Cdc42 and Rac1. (Blood. 2010;116(26):
5919-5929)
Introduction
The activation of the src-family kinase lymphocyte-specific protein
tyrosine kinase (Lck) is one of the earliest intracellular events
downstream T-cell receptor (TCR) recognition. Activated Lck
phosphorylates tyrosine residues of CD3, -chain–associated pro-
tein kinase 70, and other substrates, initiating various signaling
cascades that result in T-cell activation and proliferation.1,2 Lck is
predominantly associated with the cytosolic side of the plasma
membrane, a localization that is consistent with its importance in
TCR-mediated early signaling events.3 Transport of Lck to the
plasma membrane relies on the exocytic pathway4 and requires
addition of myristate and palmitate to the glycine and the 2 cysteine
residues of its N-terminal Gly-Cys-Val-Cys sequence.5,6 Palmitoyl-
ation/depalmitoylation of Lck can also contribute to exchange Lck
between the plasma membrane and the cytosol.7 Lck acylation is
also essential for activation of downstream signaling pathways6
and partitioning into detergent-resistant membranes5 that are
postulated to contain specialized membrane microdomains.8 MAL
is an integral membrane protein exclusively detected in detergent-
resistant membranes of epithelial cells and human T lympho-
cytes.9,10 Recent work established that MAL, which was originally
characterized as a component of the machinery for specialized
transport from the Golgi to the apical surface of polarized epithelial
cells,10-12 mediates a specialized route responsible for Lck transport
to the plasma membrane of human T cells.13 The questions remain
as to what other machinery collaborates with MAL to transport Lck
and how this process is regulated.
The important role of MAL in intracellular protein transport
implies that alterations in MAL expression or subcellular distribu-
tion could be reflected in abnormal functioning of the cells. It has
been reported that MAL is overexpressed in cutaneous T-cell
lymphoma resistant to -interferon therapy.14 Although MAL
expression is normally absent from normal B lymphocytes, MAL
expression has been found in primary mediastinal B-cell lym-
phoma15,16 and in a subset of Hodgkin lymphoma with an adverse
outcome.17,18 Therefore, in addition to the interest of the elucidation
of the mechanism of MAL-mediated transport of Lck in normal
T cells, the understanding of MAL function in normal cells would
be of great help to unveil its role in tumor cells.
The mechanism and regulation of MAL-mediated Lck trans-
port in T lymphocytes are addressed in the present paper through
the identification of human Inverted Formin2 (INF2) as a
binding partner of MAL. INF2 domain organization is similar to
that of the diaphanous-related group of formins (Drfs), which
are direct effectors of Rho-family guanosine triphosphate
(GTP)ases. Drfs mediate actin filament formation,19,20 coordina-
tion of microtubules and the actin cytoskeleton,21 and microtu-
bule stabilization.22 Drfs have an autoregulatory domain at their
carboxyl terminus, known as the diaphanous autoregulatory
domain (DAD), which is separated by formin homology (FH)
domains 1-2 from an amino-terminal diaphanous inhibitory
domain (DID). The DAD interacts with the DID to close the Drf
molecule and maintain it in an inactive state. The binding of the
effector Rho GTPase in its GTP-loaded form to the DID allows
the generation of linear actin filaments by releasing the Drf from
auto-inhibition.23 Remarkably, unlike other formins, INF2 has
the unusual ability to accelerate not only actin polymerization
but also its depolymerization.24 Herein, we report that INF2
colocalizes and interacts with MAL and that INF2 is necessary
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for normal subcellular distribution of Lck and correct formation
of immunologic synapse. Furthermore, INF2 is essential for
formation of the MAL vesicular carriers that transport Lck to
the plasma membrane of T lymphocytes. The MAL vesicular
carriers transporting Lck move along microtubule tracks in a
process that is dependent on the actin polymerization and
depolymerization activities of INF2. We have also found that
Lck targeting is regulated by the Rho-family GTPases Cdc42
and Rac1, which bind the DID of INF2. Our results reveal a
pathway whereby Rac1, Cdc42, INF2, and MAL regulate the
targeting of Lck to the plasma membrane of T lymphocytes.
Methods
Reagents and antibodies
The mouse monoclonal antibody (mAb) 6D9 to human MAL9 and the
rabbit polyclonal antibodies to INF225 have been described previously. The
mouse mAb DM1A to -tubulin was purchased from Sigma-Aldrich; the
mAb and the rabbit polyclonal antibodies to Lck were from BD Bio-
sciences. The mAb to CD3 and that to murine CD4 were kindly provided by
Dr Alarco´n (Centro de Biología Molecular Severo Ochoa) and Dr Rojo
(Centro de Investigaciones Biolo´gicas, Madrid, Spain), respectively. The
antibodies to RhoA, Rac1, and Cdc42 were from BD Biosciences. The
anti–glyceraldehyde 3-phosphate dehydrogenase (GADPH) antibody was
from Santa Cruz Biotechnology. Fluorescent secondary anti–rabbit or
anti–mouse immunoglobulin G antibodies and tetramethylrhodamine iso-
thiocyanate (TRITC)–phalloidin were obtained from Molecular Probes
(Invitrogen). Secondary anti–rabbit or anti–mouse immunoglobulin G
antibodies coupled to horseradish peroxidase were from Jackson ImmunoRe-
search Laboratories.
Cell-culture conditions
Human T lymphoblastoid Jurkat cells were grown in RPMI 1640 supple-
mented with 10% fetal bovine serum (Sigma-Aldrich), 50 U/mL penicillin,
and 50 g/mL streptomycin at 37°C in an atmosphere of 5% CO2/95% air.
For formation of T-cell–antigen-presenting cell conjugates, Raji B cells
(3.0  106 cells/mL) were incubated for 20 minutes in the presence or
absence of 4 g/mL staphylococcal enterotoxin E superantigen (Toxin
Technology) and mixed with an equal number of Jurkat cells (5.0  105
cells/well) in a final volume of 50 L, incubated at 37°C for 15 minutes and
plated onto poly(L)lysine-coated slides. For experiments with human
primary T cells, freshly isolated T lymphocytes from healthy donors were
used following the guidelines of the Bioethics Committee of the Spanish
Research Council and with the approval of the institutional management
committee of the Centro de Biología Molecular “Severo Ochoa”
(Madrid, Spain).
Analysis of direct interactions by the yeast 2-hybrid system
Paired baits (pAS2-1 constructs) and preys (pACT2 or pAD-GAL4
constructs) were transfected into Hf7c cells, as described elsewhere,26 and
their interactions assessed by qualitatively determining His3 reporter gene
activity.27 All constructs used were verified by DNA sequencing. Control
prey constructs encoding D52-like fusion proteins have been described
elsewhere.28
Figure 1. Characterization of INF2 as a MAL-interacting protein and analysis of its subcellular distribution in Jurkat cells. (A) Yeast HF7C strain cells were
cotransformed with the pAD-GAL4 255C1 cDNA obtained in the yeast 2-hybrid screen and bait constructs encoding either full-length MAL or MAL2 or the indicated D52-like
prey proteins as negative controls. Yeast growth on solid media at 30°C was evaluated as follows: –, no growth after 6-8 days; , growth after 3-4 days; , growth after
1-2 days. Identical results were obtained for all 3 D52-like proteins. (B) Schematic of the INF2-1 proteins expressed in the experiments in this Figure. (C) The 1% Triton-X-100
insoluble (I) membrane fraction of Jurkat cells was separated from the soluble fraction (S) and, after solublization with 60mM octyl-glucoside, was subjected to pull-down
analysis with GST alone or fused to the indicated INF2 fragments. The presence of endogenous MAL was determined by immunoblotting with mAb 6D9 (top). The Coomassie
blue staining of the GST proteins used is shown (bottom). (D) Jurkat cells transiently transfected (top) or not (bottom) with Cherry-MAL were stained for endogenous INF2 using
anti-INF2 antibodies and secondary antibodies coupled to Alexa-488 (top) or for INF2, -tubulin, and F-actin using antibodies to INF2 and -tubulin and secondary antibodies
coupled to Alexa-488 or Alexa-647 and with TRITC-phalloidin, respectively (bottom). (E) Jurkat cells transiently expressing GFP fused to INF2-1 or INF2-2 were fixed and
stained for -tubulin and F-actin with anti–-tubulin antibodies followed by secondary antibodies coupled to Alexa-647 and with TRITC-phalloidin, respectively. (F) Jurkat cells
transiently expressing GFP fusions of the indicated fragments of INF2-1 were used to analyze the distribution of -tubulin and F-actin with anti–-tubulin antibodies followed by
secondary antibodies coupled to Alexa-647 and TRITC-phalloidin, respectively. A representative x/y plane is shown in each case. A deconvoluted enlargement of the
pericentriolar region (boxed region) is included in the case of Cterm1-transfected cells to show that Cterm1 surrounds the microtubule-organizing center. A pile-up of 2 medial
confocal stacks is presented in D-E. The staining of F-actin is presented in gray in D-F to help its visualization. A Nomarsky image of the cell field is included in all the cases.
Scale bars correspond to 5 m unless other value is indicated.
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DNA constructs and transfection conditions
The DNA constructs expressing green fluorescent protein (GFP) or Cherry
fusions of wild-type INF2-1, INF2-2,or INF2-1 proteins with point
mutations in sequences encoding the FH2 and/or the DAD (INF2-K/A;
INF2-3L/A, and INF2-K/A-3L/A mutants) as well as the constructs
expressing INF2 fragments or glutathione transferase (GST)-INF2 fusion
proteins are described elsewhere.25 The constructs used for expression of
INF2 proteins in Jurkat cells contain only the coding sequence of the INF2
mRNA, and, therefore, their expression products are resistant to knock-
down by shINF2b, which targets the 3 untranslated region. The constructs
expressing GFP fusions of INF2C or Cterm1 were obtained by standard
procedures. The sequences of all constructs were verified by automated
sequencing. The pMAL-shRNA/GFP constructs that coexpress GFP and
shRNAs specific to human MAL as well as the constructs expressing the
Cherry protein appended to the carboxyl terminus of Lck (Lck-Cherry) or
the amino terminus of MAL (Cherry-MAL) have been described previ-
ously.13 The DNA constructs for expression of GFP fused to Rho GTPases
or GST fused to the Rho GTPase-binding domain of PAK1 (GST-PBD) or
Rhotekin (GST-RBD) and the plasmid expressing EB3-GFP were generous
gifts from Dr J. Milla´n (Centro de Biología Molecular, Madrid, Spain). The
plasmid expressing GFP-tubulin was from Clontech and that expressing
p75-GFP29 was a kind gift from Dr Rodriguez-Boulan (Cornell University,
New York, NY). The DNA construct expressing the ectodomain and
transmembrane region of murine CD4 fused to Lck (CD4/Lck) has been
described elsewhere.30 The sequences 5 GTACCGCTTCAGCATTGTC 3
or 5 CTTGGCCATCACATCAACA 3, which target the coding or 3
untranslated region, respectively, of INF2 mRNA, separated by a short
spacer (5-TTCAAGAGA-3) from their reverse complement was cloned
under the control of the H1-RNA promoter in the pSuper-Retro-GFP
(Oligoengine) vector to generate the plasmids coexpressing GFP and
shRNAa or shRNAb specific to human INF2, respectively. The plasmids
coexpressing GFP and shRNA specific to human RhoA, Rac1, and Cdc42
were from SABiosciences. The GFP coding sequence was replaced by that
encoding the Cherry protein in the construct expressing shRNA to Cdc42
using standard procedures. Jurkat cells and primary human T cells were
transfected by electroporation using the Gene Pulser system (Bio-Rad
Laboratories). To evaluate the extent of protein knockdown using the
shRNA expressing constructs, GFP-expressing cells were separated in a cell
sorter and analyzed by immunoblotting with the appropriate antibodies.
Confocal microscopic analysis
Cells were fixed in 4% paraformaldehyde for 15 minutes, rinsed, and
treated with 10mM glycine for 5 minutes to quench the aldehyde groups.
The cells were permeabilized or not with 0.1% Triton X-100, rinsed, and
incubated with 3% bovine serum albumin in phosphate-buffered saline for
15 minutes. Cells were then incubated for 1 hour with the appropriate
primary antibodies, rinsed several times, and incubated for 30 minutes with
the appropriate combination of secondary antibodies coupled to Alexa-488,
Figure 2. INF2 knockdown blocks the exit of MAL vesicles from perinuclear endosomes and decreases the expression of MAL at the plasma membrane.
(A-C) Wild-type Jurkat cells (A) or Jurkat cell transiently expressing Cherry-MAL (B-C) were transfected or not (NT) with a DNA construct coexpressing GFP and shControl, or
shINF2a or shINF2b, which are targeted to the coding or 3 untranslated regions, respectively, of INF2 mRNA. Cells were processed for immunoblotting with anti-INF2
antibodies to examine the levels of INF2 or with anti-GADPH antibodies as a loading control (A, top). The 1% Triton-X-100 insoluble (I) membrane fraction of Jurkat cells was
separated from the soluble fraction (S), and equivalent aliquots were immunoblotted for MAL and Lck (A bottom). Cells were also processed for fluorescence microscopy to
analyze the distribution of MAL (B-C). The intensity of MAL staining in Jurkat cells was measured by densitometric analysis along rectilinear lines as that shown in a
representative experiment (C, left). Arrows indicate the position of the periphery of the cell (C middle). The histogram shows the mean percentage  SEM of cells with low
levels of MAL at the plasma membrane as measured as described in “Methods” (C right). Staining intensity was measured in 	 50 cells per experiment. Three independent
experiments were performed (*P 
 .05). (D) Jurkat cells transiently expressing Cherry-MAL were transfected with a plasmid coexpressing GFP and shControl or shINF2a for
48 hours, the activity being captured with time-lapse videomicroscopy. Transfected cells were identified by expression of GFP (small top panel). The processes occurring in the
cell (large bottom panel) within the boxed region are shown at higher magnification in the right panels. Solid and empty arrowheads indicate 2 vesicles transporting MAL from
the pericentriolar region to the plasma membrane or from the plasma membrane to the pericentriolar region, respectively. Numbers indicate time in seconds. Scale bars
correspond to 5 m unless other value is indicated.
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Alexa-594, or Alexa-647. Actin filaments were detected with TRITC-
phalloidin. Coverslips were mounted with Fluoromount (Sigma-Aldrich).
Controls to assess labeling specificity included incubations with, or
omitting, control primary antibodies. For the quantitative analysis of MAL
or Lck distribution, their fluorescence signal was profiled along a line at the
equatorial plane of the cell using National Institutes of Health ImageJ
Version 1.43m software (http://rsb.info.nih.gov/ij/). The ratio of internal to
plasma membrane fluorescence was calculated for each type of Jurkat cell
in 3 independent experiments (n  50 cells for each type of cell). Cells with
a ratio greater than 2-fold the mean value of normal Jurkat cells were
considered to express low levels of Lck at the plasma membrane.
Approximately 48% and 36% of wild-type Jurkat cells met this criterion for
MAL and Lck, respectively. Images were obtained by confocal microscopy
using an LSM510 META system (Carl Zeiss) coupled to an inverted
Axiovert 200 microscope. A 63/1.4 oil Plan Apochromat objective was
used. For time-lapse experiments, cells were maintained at 37°C in Hanks
balanced salt solution supplemented with 5% fetal bovine serum. Cell
images were captured at 11-second intervals for simultaneous videomicros-
copy of Cherry-MAL and GFP-tubulin, every 1.6 seconds in the case of
Cherry-MAL and EB3-GFP or every 6 seconds in the case of the individual
tracking of Cherry-MAL or Lck-Cherry. Images were analyzed with
MetaMorph B.2r6 imaging software (Molecular Devices). Some images
were deconvoluted with Huygens 3.0 software (Scientific Volume Imag-
ing). Images were exported in TIFF format, and their brightness and
contrast were optimized with Adobe Photoshop.
Pull-down assays
For INF2-MAL pull-down assays, the detergent-insoluble membrane
fraction of Jurkat cell was solubilized with 60mM octyl-glucoside and was
incubated with 10 g of GST or GST-INF2 proteins immobilized on
GSH-Sepharose beads (GE Healthcare Life Sciences) for 1 hour at 4°C in
lysis buffer (10mM MgCl in 25mM Tris-HCl, pH 7.5, 150mM NaCl, 5mM
EDTA [ethylenediaminetetraacetic acid], 1% Triton X-100). Beads were
washed 3 in lysis buffer, and MAL was detected by immunoblotting with
anti-MAL mAb 6D9 using the enhanced chemiluminescence detection kit
Figure 3. INF2 knockdown blocks the formation of
exocytic transport vesicles containing Lck and de-
creases the expression of Lck at the plasma mem-
brane. (A) The subcellular distribution of endogenous
Lck was analyzed in Jurkat cells coexpressing GFP and
shControl, shINF2a, or shINF2b using anti-Lck antibod-
ies followed by secondary antibodies coupled to Alexa-
647 antibodies. Lck staining intensity was measured by
densitometric analysis along rectilinear lines as de-
scribed for MAL in Figure 2C. The histogram shows the
mean percentage  SEM of cells with low levels of
peripheral Lck or TCR/CD3. (B-C) Jurkat cells transiently
expressing Lck-Cherry (B) or p75-GFP (C) were cotrans-
fected with a construct coexpressing GFP and shControl
or shINF2a (B) or Cherry and shControl or shINF2a (C)
for 48 hours, the activity being captured with time-lapse
videomicroscopy. Transfected cells were identified by
expression of GFP (B) or Cherry (C). The processes
occurring in the cell within the boxed regions are shown
at higher magnification in the right panels. Arrowheads
indicate 2 vesicles transporting Lck to the plasma mem-
brane. Numbers indicate time in seconds. (D) Jurkat cells
transiently expressing GFP fusions of INF2-1 or Cterm1
were stained for endogenous Lck using anti-Lck antibod-
ies and secondary antibodies coupled to Alexa-647 (left).
The histogram shows the mean percentage  SEM of
cells with low levels of peripheral Lck. (E) Jurkat cells
transiently expressing GFP fused to Cterm1 were stained
for endogenous INF2 using anti-INF2 antibodies and
secondary antibodies coupled to Alexa-594 and with
TRITC-phalloidin. The staining of F-actin is presented in
gray. (F) Jurkat cells coexpressing GFP (top) and the
indicated shRNA or a trasmembrane CD4/Lck chimera
(bottom) were conjugated to staphylococcal enterotoxin
E–pulsed antigen presenting cells (APCs) for 15 minutes.
After cell fixation, the distribution of TCR/CD3 and F-actin
was analyzed with anti-CD3 antibodies and secondary
antibodies coupled to Alexa-647 and with TRITC-
phalloidin, respectively. The staining of TCR/CD3 was
pseudocolored in green and that of GFP in gray to help
visualization of the distribution of TCR/CD3. The cells
expressing CD4/Lck were identified with anti–mouse
CD4 mAb and secondary antibodies coupled to Alexa-
488 (bottom). (G) The histogram represents the mean
percentage of transfected Jurkat cells in T-cell–APC
conjugates displaying polarized distribution of F-actin or
TCR/CD3 to the IS. Three independent experiments
were performed in panels A, D, G; n 	 50 T cells/
experiment (**P 
 .01). Scale bars correspond to 5 m
unless other value is indicated.
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(GE Healthcare Life Sciences). For Rho GTPase pull-down, cells were
lysed in 50mM Tris-HCl, pH 7.4, 1mM MgCl2, 2mM EDTA, 300mM NaCl,
0.5% Nonidet P-40, 10% glycerol containing a cocktail of protease
inhibitors. Preloading of endogenous Rho GTPases was performed in cell
lysates incubated with 50 M 5-guanylyl-imidodiphosphate trisodium salt
hydrate (GMP-PNP; Roche Applied Science) for 10 minutes at 30°C. The
reaction was stopped by adding MgCl2 to a final concentration of 10mM.
For binding assays, 10 g of GST proteins were incubated for 1 hour at 4°C
in lysis buffer containing 10mM MgCl2 with the lysates preloaded with
GMP-PNP. The beads were washed 3 in interaction buffer, and bound
proteins were analyzed by Western blotting with anti-RhoA, -Rac1, or
-Cdc42 mAbs.
Statistical analysis
Data are expressed as mean  SEM. A paired Student t test was used to
establish the statistical significance of differences between the means.
Results
Identification of human formin INF2 as a MAL-interacting
protein
The isoform 1 of formin INF2 (INF2-1) was isolated during a
yeast 2-hybrid screen as a binding partner of MAL2,25 a member
of the MAL family of proteins originally identified in a yeast
2-hybrid screen by its interaction with tumor protein D52L2.27
INF2-1 fragments containing the carboxyl-terminal 255 amino
acids, referred to as 255C1, or the entire carboxyl terminal
domain (Cterm1), were shown to be sufficient for the interaction
with MAL2 in yeast 2-hybrid and pull-down experiments,
respectively.25 Using the same type of assays, we found that the
same INF2 fragments also interacts with MAL (Figure 1A-C).
As control baits in the yeast 2-hybrid assay, we used distinct
D52-like proteins,28 which interacted specifically with MAL2
but not with MAL (Figure 1A). The equivalent region of the
INF2-2 isoform, known as Cterm2, which differs from Cterm1
in the carboxyl-terminal 18-amino acid sequence, also bound
MAL whereas the FH2DAD fragment did not (Figure 1C).
Immunofluorescence analysis of Jurkat T cells indicated that
endogenous INF2 is distributed at the cell periphery, pericentrio-
lar region, and microtubule cytoskeleton (Figure 1D). As
expected, given their physical interaction, we found a high level
of colocalization between endogenous INF2 and MAL in Jurkat
cells (Figure 1D). Expression of exogenous INF2-1 and INF2-2
in Jurkat cells reproduced the distribution of endogenous INF2
(Figure 1E). In keeping with its interaction with MAL, Cterm1
distributed to the cell periphery, although to a lesser extent than
did intact INF2-1, and to the pericentriolar region and microtu-
bules as observed for the entire molecule. However, INF2-1
with the Cterm1 deleted (INF2-C) was exclusively targeted to
the cell periphery (Figure 1F). Therefore, Cterm1 is responsible
Figure 4. MAL transport vesicles move along micro-
tubule tracks. (A-B) Jurkat cells coexpressing GFP-
tubulin and Cherry-MAL (A) or Lck-Cherry (B) were fixed
and analyzed by confocal microscopy. Enlargements of
the boxed regions are shown on the right. The arrows
indicate MAL (A) or Lck (B) vesicles associated with
microtubules. (C-D) Jurkat cells were cotransfected with
plasmids expressing Cherry-MAL and GFP-tubulin (C) or
EB3-GFP (D). After 24 hours, cells were subjected to
time-lapse videomicroscopy. The image of a representa-
tive cell is shown. Selected frames corresponding to
events occurring in the boxed regions during the time-
lapse experiment are shown. In panel C, the solid and
empty arrowheads indicate 2 MAL vesicles that move to
the plasma membrane or to the pericentrosomal region,
respectively, along microtubule tracks. In panel D, the
arrowhead indicates a MAL vesicle moving along a
microtubule labeled at its plus tip with EB3, which is
indicated by an arrow. Two different areas from the same
cell are enlarged in panel D. (E) Jurkat cells coexpressing
GFP and shINF2a or transfected with the indicated INF2
construct were fixed, permeabilized, and stained with
anti–-tubulin antibodies followed by Alexa-488 second-
ary antibodies and with TRITC-phalloidin. The cells
expressing the exogenous INF2 fragment were identified
with anti-INF2 antibodies and secondary antibodies
coupled to Alexa-647 (bottom). The staining of exog-
enous INF2 is presented in gray. (F) Jurkat cells coex-
pressing the Cherry protein and the indicated shRNA
from the same plasmid were transfected with EB3-GFP
and processed for time-lapse videomicroscopy. Arrows
indicate microtubules labeled with EB3 at their growing
end. Numbers in panels C, D, and F indicate time in
seconds. Scale bars correspond to 5 m unless another
value is indicated.
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for the interaction of INF2-1 with MAL and its targeting to the
pericentriolar region and microtubules.
INF2 knockdown impairs the formation of transport vesicles
containing MAL and produces its intracellular accumulation
To investigate the possible role of INF2 in MAL distribution and
function, we used a loss-of-function strategy by using expression of
shRNAs (shINF2a and shINF2b) specific to human INF2 mRNA
using DNA constructs that simultaneously express GFP to identify
the transfected cell population. Expression of shINF2a and shINF2b
reduced the levels of endogenous INF2 to 15%-20% of control
shRNA (shControl)-transfected cells without affecting the content
of MAL or Lck (Figure 2A). Whereas the distribution of MAL was
unaffected in shControl-transfected cells, INF2 knockdown greatly
reduced the levels of MAL at the cell periphery, pericentriolar
region, and radial microtubules, resulting in the intracellular
accumulation of MAL (Figure 2B-C). We previously showed that
MAL is a dynamic protein that travels in vesicular structures from
pericentriolar endosomes to the cell surface for cargo delivery.13 To
examine the requirement of INF2 for the formation of the
MAL-positive vesicular carriers, we compared the dynamics of
MAL in Jurkat cells with normal or silenced levels of INF2 (Figure
2D and supplemental Video 1, available on the Blood Web site; see
the Supplemental Materials link at the top of the online article).
Whereas MAL-positive vesicles continuously egressed from the
pericentriolar region and reached the plasma membranes following
linear tracks in control cells, the exit of MAL-positive vesicles was
almost completely blocked in INF2-silenced cells. This implies that
INF2 expression is necessary for the normal distribution and
dynamics of MAL in Jurkat cells.
INF2 is necessary for transport of Lck to the plasma membrane
MAL has been previously shown to be essential for the transport of
Lck to the plasma membrane of human T lymphocytes.13 Because
INF2 expression is required for MAL dynamics (Figure 2), we
investigated the targeting of Lck to the plasma membrane in
INF2-knockdown cells. Consistent with the defect on MAL
dynamics, Lck was practically absent at the plasma membrane and
accumulated intracellularly in INF2-silenced cells (Figure 3A).
The distribution of TCR/CD3, used as a control, was not affected
Figure 5. The actin polymerizing and depolymerizing
activities of INF2 are both required for efficient
targeting of Lck to the plasma membrane. (A) The
alignment shows the conservation of Lys1601 in the FH2
domain of Bnp1 in the corresponding position of mDia1,
mDia2, and human and mouse INF2 and the position of
the 3 Leu residues critical for F-actin depolymerization in
the DAD sequence of mouse and human INF2. Note that
the third Leu residue is not present in the Bnp1 or
mDia1-2 formins. The residues mutated to alanine in the
K/A, 3L/A, and K/A-3L/A INF2-1 mutants are indicated.
(B-C) Jurkat cells coexpressing GFP and shControl or
shINF2b from the same plasmid were cotransfected with
expression plasmids encoding intact Cherry fusions of
full-length INF2-1 or INF2-1 proteins with the indicated
mutations for 48 hours. The expression of these proteins
is resistant to shINF2b as their mRNA lack the INF2 3
untranslated region to which shINF2b is targeted. Cells
were fixed, permeabilized, and subjected to immunofluo-
rescence analysis with anti-Lck antibodies and second-
ary antibodies coupled to Alexa-647 (Lck; B). The stain-
ing of INF2-1 was pseudocolored in green and that of
GFP in gray to help visualization of the distribution of
INF2-1. The histogram shows the mean per-
centage  SEM of cells with low levels of peripheral Lck
(C). (D) Jurkat cells were treated with 0.1% dimethyl
sulfoxide, 1M Lantrunculin A (LatA), 2.5M Cytochala-
sin D (CytD), or 0.5M Jasplakinolide (Jasp) for 1 hour.
Cells were then fixed and stained for F-actin, Lck, and
-tubulin using TRITC-phalloidin and the appropriate
primary antibodies followed by secondary antibodies
coupled to Alexa-647 (Lck) or Alexa-488 (-tubulin).
(E) The histogram shows the percentage  SEM of cells
with low levels of peripheral Lck. (F) Jurkat cells express-
ing Lck-GFP for 24 hours were treated with Lantrunculin
(LatA) 30 seconds after start, being subjected to time-
lapse videomicroscopy. Numbers indicate time in sec-
onds. (G) Jurkat cells expressing GFP fusions of MAL,
Lck, or p75 were incubated for the indicated times in the
presence of 100M nocodazole and analyzed under a
confocal microscope. The histogram shows the percent-
age of cells  SEM with low levels of peripheral MAL,
Lck, or p75. The distribution of p75 is presented in gray.
The mean  SEM of 3 independent experiments is
represented in panels C,E,G. Staining intensity in was
measured in 	 50 cells per experiment; 3 independent
experiments were performed (*P 
 .05; **P 
 .01). Scale
bars indicate 5 m.
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by INF2 silencing (Figure 3A). Furthermore, when we compared
the dynamics of Lck in Jurkat cells with either normal or silenced
levels of INF2, we observed that formation of the exocytic vesicles
transporting Lck to the plasma membrane was almost completely
impaired in INF2-silenced cells (Figure 3B and supplemental
Video 2), whereas transport of the transmembrane protein p75
occurred normally (Figure 3C). Consistent with the interaction of
MAL with the Cterm1 domain, overexpression of Cterm1 in Jurkat
cells considerably increased the percentage of cells with low
expression of Lck at the plasma membrane (Figure 3D). We did not
detect any change in the overall distribution of endogenous INF2 in
cells overexpressing Cterm1 (Figure 3E), indicating that probably
only a small subpool of INF2 collaborates with MAL-mediating
Lck transport. Similar to MAL-deficient Jurkat cells,13 which also
express low levels of Lck at the plasma membrane, the transloca-
tion of the TCR to the immunologic synapse in T cells with
silenced levels of INF2 cells was impaired whereas F-actin
polarized normally (Figure 3F-G). The failure of immunologic
synapse formation was mostly due to the reduced presence of Lck
at the plasma membrane, since forced expression of Lck at the
plasma membrane using a transmembrane CD4/Lck chimera
restored TCR targeting to the immunologic synapse (Figure 3F-G).
MAL was detected along microtubule arrays radiating from the
centrosomal region in Jurkat cells at steady state (Figure 1D). To
investigate the possible involvement of microtubules in MAL and
Lck trafficking, Jurkat cells were cotransfected with plasmids
expressing GFP-tubulin, and Cherry-MAL or Lck-Cherry and were
examined by confocal microscopy in unpermeabilized cells to
preserve better the distribution of these proteins that, otherwise,
might be altered by the detergent permeabilization procedure.
MAL was found to distribute in discrete vesicular structures along
microtubules (Figure 4A). Transport vesicles containing Lck were
found to be associated along microtubules as well (Figure 4B).
Moreover, we observed by time-lapse videomicroscopy a continu-
ous exit of MAL-positive vesicles that used microtubule tracks
during their movement from the pericentriolar region toward the
plasma membrane (Figure 4C). Retrograde trafficking of MAL
vesicles from the plasma membrane to the pericentriolar region was
also observed. Apparently, the anterograde movement of MAL took
place along microtubule growing toward the plasma membrane. To
Figure 6. Cdc42 and Rac1 are necessary for targeting
Lck to the plasma membrane in Jurkat cells. (A) Jur-
kat cell extracts were loaded or not with GTP analog
GMP-PNP and incubated with GST alone or fused to the
indicated fragments of INF2. As controls, the Rho-
GTPase binding domains of rhotekin (RBD) or PAK1
(PBD) were used to detect active RhoA or Rac1 and
Cdc42, respectively. Ten percent of the original extract
was immunoblotted in parallel. (B-C) Jurkat cells express-
ing GFP and shRNA control or shRNA targeted to RhoA,
Cdc42, or Rac1 from the same plasmid were analyzed by
immunoblotting with antibodies to the indicated proteins
(B). As a loading control, the levels of GADPH were
examined. Cells were also fixed, permeabilized, and
stained for Lck (C). Double transfectants expressing
shRac1 and shCdc42 from plasmids which coexpress
GFP and Cherry, respectively, were also analyzed in
panel C. (D) Jurkat cells expressing GFP fusions of
Rac1V12, Cdc42V12, Rac1N17, or Cdc42N17 for
24 hours were stained for Lck. Anti-Lck antibodies and
secondary antibodies coupled to Alexa-647 were used in
panels C-D to detect Lck. (E) The percentage of cells with
low levels of peripheral Lck in cells with silenced expres-
sion or overexpression of the indicated Rho-family
GTPases was quantified and summarized as
means  SEM from 3 independent experiments. More
than 50 transfected cells were scored in each experiment
(**P 
 .01). (F) Jurkat cells transfected with GFP fusions
of Rac1V14 or Cdc42V14 for 24 hours were stained for
endogenous INF2 using anti-INF2 antibodies and second-
ary antibodies coupled to Alexa-594. The images shown
were deconvoluted. The right panels show plots of
colocalization of Rac1V14 or Cdc42V14 with INF2. The
Pearson correlation coefficient (r) was 0.75 and 0.87 for
Rac1V14/INF2 and Cdc42V14/INF2, respectively. Four
independent experiments were performed. Scale bars
indicate 5 m.
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investigate this point further, we monitored simultaneously the
movement of Cherry-MAL and GFP-EB3, a protein associated
with the plus-growing tip of elongating microtubules.31 We found
that MAL vesicles moved along the tracks delineated by EB3 but
were not associated with the microtubule tip since MAL moved
behind EB3 (Figure 4D). INF2 silencing affected neither the steady
state distribution of microtubules and filamentous actin (Figure 4E)
nor microtubule dynamics (Figure 4F). Consistent with the effect
of other Drfs,21 the overexpression of a constitutive active mutant
of INF2 produced alignment of actin filaments and microtubules
(Figure 4E). The results in Figure 4, therefore, indicate that the
MAL vesicular carriers move to the plasma membrane following
tracks of newly formed microtubules in a process probably
coordinated by INF2.
Lck transport requires both the actin polymerization and
depolymerization activities of INF2
Actin assembly has been shown to power the movement of
intracellular vesicles and even intracellular pathogens.32,33 Muta-
tion of Lys1601 in the FH2 domain of the yeast Drf Bni1p34 or in the
equivalent position of mDia222 impairs the actin nucleation activity
of these formins. On the other hand, mutation of 3 critical leucine
residues in the DAD of mouse INF2 abrogates its in vitro
depolymerization activity.24 We introduced the same mutations at
the equivalent position of human INF2 to generate the K/A, 3L/A,
and K/A-3L/A INF2 mutants (Figure 5A) with altered actin
polymerization and/or depolymerization activities and used them to
determine whether they are able to replace the function of
endogenous INF2 in Lck transport. To this end, the transcripts
encoding the exogenous INF2 proteins were designed to resist
shINF2b expression. In contrast to the expression of intact INF2-1,
none of the INF2 mutants was able to restore Lck transport when
expressed (Figure 5B-C). The failure of these mutants to substitute
endogenous INF2 indicates that both actin polymerization and
depolymerization activities of INF2 are required for efficient
targeting Lck to the plasma membrane. Consistent with the
observed requirement of actin dynamics for Lck transport, treat-
ment of Jurkat cells with different inhibitors that produce depoly-
merization (Latrunculin A and Cytochalasin D) or stabilization
(Jasplakinolide) of actin filaments reduced the Lck levels at the
plasma membrane and accumulated the protein in the pericentriolar
region (Figure 5D-E). The loss of Lck from the plasma membrane
after inhibition of actin polymerization with Lantrunculin A was
concomitant with a block in the exit of Lck vesicular carriers from
pericentriolar endosomes and the accumulation of Lck at this
location (Figure 5F), instead of it being distributed throughout the
cytosol as would have been expected if Lantrunculin A simply
dissociated Lck from the plasma membrane. Consistent with the
results shown in Figure 4, microtubule integrity was required for
the targeting of MAL, Lck, and, in agreement with previous
observation in other cell types,29,35 p75 to the plasma membrane as
observed in cells treated with the microtubule-disrupting drug
nocodazole (Figure 5G).
Cdc42 and Rac1 regulate Lck transport to the plasma
membrane
To investigate the binding of Rho-family GTPases to the DID of
INF2, we performed pull-down assays using lysates of Jurkat cells
in which endogenous Rho GTPases were enriched or not in their
GTP-loaded form (Figure 6A). Both Rac1 and Cdc42 bound to the
DID fragment under both conditions although to a larger extent in
their GTP-loaded form. No binding of RhoA was observed in either
case. Similar results were obtained using lysates of hepatoma
HepG2 cells.25 To investigate whether any of these Rho-family
GTPases regulate Lck transport to the plasma membrane, we
carried out knockdown experiments using specific shRNA (Figure
6B). The silencing of Cdc42 and Rac1, but not that of RhoA,
recapitulated the effect of INF2 (Figure 3) or MAL silencing13 on
the targeting of Lck to the plasma membrane (Figure 6C,E). It is
worth noting that the double knockdown of Cdc42 and Rac1
increased the percentage of cells with low levels of Lck at the
plasma membrane compared with the single knockdowns (Figure
6C,E), suggesting that Rac1 and Cdc42 function at different
moments during Lck transport. To investigate further the role of
Rac1 and Cdc42 in this process, we examined the effect of the
expression of constitutive active (Rac1V14 and Cdc42V14) or
dominant negative (Rac1N17 and Cdc42N17) forms of these 2 Rho
GTPases. It is of particular note that in all the cases the cells
presented a predominant intracellular accumulation of Lck and
very low levels of expression at the plasma membrane (Figure
6D-E). In agreement with a role of Rac1 and Cdc42 on INF2
regulation, we found that these 2 Rho-family GTPases colocalize
Figure 7. Cdc42, Rac1 and INF2 are necessary for targeting of Lck to the plasma
membrane in human primary T cells. (A) Human primary T cells expressing GFP
and shControl or shRNA targeted to Rac1, Cdc42, INF2, or MAL from the same
plasmid were fixed, permeabilized, and stained for Lck using anti-Lck antibodies and
secondary antibodies coupled to Alexa-647. Note that Lck is almost exclusively
detected at the plasma membrane in control primary T cells. (B) The histogram
represents the mean percentage  SEM of cells with an intracellular accumulation of
Lck. Three independent experiments were performed; 	 50 transfected cells were
scored in each experiment (**P 
 .01). Scale bar indicates 5 m.
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partially with INF2 (Figure 6F). In conclusion, both Cdc42 and
Rac1 and their GTPase hydrolysis activity are required for exocytic
transport of Lck to the plasma membrane.
It is apparent that the effect of INF2, Cdc42, and Rac1
knockdown on Lck targeting to the plasma membrane was not
restricted to Jurkat cells as similar experiments in primary
T lymphocytes also resulted in diminished expression of Lck at the
cell periphery and to its intracellular accumulation (Figure 7).
Thus, Lck transport was strictly dependent on Cdc42, Rac1, INF2,
and MAL expression in Jurkat cells and primary T lymphocytes.
Discussion
Lck expression at the plasma membrane is critical for its signaling
function in T lymphocytes.6 It is established that Lck relies on the
exocytic pathway for targeting to the cell surface.4 In Jurkat cells,
MAL colocalizes extensively with Lck in pericentriolar endosomes
and exit together from this location in the same transport vesicles
destined for the plasma membrane. Because the formation of the
vesicles transporting Lck is severely impaired in cells with silenced
MAL expression, MAL was proposed to be an element of the
machinery for transporting Lck to the T cell plasma membrane.13
Despite its crucial role, it is obvious that Lck targeting should
involve other molecules that collaborate with MAL in this task. The
INF2 formin has recently been implicated in the formation of
transcytotic MAL2 vesicles that transport cargo from the basolat-
eral to the apical surface of epithelial cells.25 In the present study,
we show that INF2 interacts with MAL and mediates the formation
of MAL vesicular carriers that transport Lck to the plasma
membrane of T cells. This mechanism is compatible with exchange
mechanisms between the plasma membrane and the cytosol based
on palmitoylation/depalmitoylation of Lck.7 The interaction with
MAL involved the carboxyl-terminal Cterm domain of INF2-1,
which is not conserved in other formins. The overexpression of this
fragment reduced the expression of Lck at the plasma membrane,
probably by competing with endogenous INF2 to bind to MAL.
Moreover, INF2 knockdown blocked the formation of transport
carriers for Lck, caused the intracellular accumulation of Lck, and
impaired the formation of a normal immunologic synapse, evoking
the effect of MAL silencing.13 Moreover, knockdown of either
Rac1 or Cdc42, which bind INF2, produced the intracellular
accumulation of Lck in both Jurkat cells and primary T cells.
Therefore, ours results are consistent with a model by which Rac1
and Cdc42 control Lck targeting to the plasma membrane by
regulating MAL dynamics through INF2.
Formin mDia1 is induced during T-cell activation and regulates
actin polymerization and cell migration.36 Consistently, T cells
from mDia1 knockout mice are defective in migration and prolifera-
tion in response to chemotactic or proliferative stimuli, respec-
tively.37,38 In other cell types, formins mDia1-3 modulate endo-
some movement through cycles of assembly and disassembly of
actin filaments.39-41 Formins mDia1-3 are responsible for F-actin
assembly, but disassembly requires the participation of additional
proteins with severing and depolymerizing activities. A distinctive
feature of INF2, compared with the mDia1-3 Drfs, is its in vitro
capacity both to nucleate and depolymerize actin filaments.24
Therefore, unlike other formins that only polymerize actin, INF2
can do the entire job of actin polymerization-depolymerization that
is required for the formation/movement of vesicular transport
carriers. Indeed, our results show that the polymerization and
depolymerization activities of INF2 are both required for Lck
targeting to the plasma membrane of T cells, suggesting that Lck
transport requires actin dynamics. This requirement is consistent
with our observation that treatment of Jurkat cells with either
Latrunculin A, which binds to actin monomer, Jasplakinolide,
which stabilizes actin filaments, or Cytochalasin D, which binds
and caps the barbed (fast-growing) end of actin filaments, inter-
fered with the targeting of Lck to the plasma membrane. In cells
with actin polymerization inhibited by Lantruculin A, there was a
block in the exit of transport vesicles with Lck from pericentriolar
endosomes paralleled by an increased presence of Lck at those
endosomes instead of it being distributed throughout the cytosol as
would have been expected if the inhibition of actin polymerization
simply dissociated Lck from the plasma membrane. The possibility
remains that the dissociated Lck molecules associate very rapidly
to internal membranes. It is of particular note that the movement of
the MAL vesicular carriers that transport Lck takes place along
microtubules and requires microtubule integrity. This observation
is consistent with the alignment of actin filaments and microtubules
induced by constitutively active INF2. Src transport to the plasma
membrane is regulated by RhoB and mDia1 and requires actin
polymerization but not microtubule integrity.42,43 Therefore, al-
though the processes of Src and Lck transport are regulated by
Rho-family GTPases and formin proteins, their mechanisms appear
to be different.
The DID of the INF2 molecule interacts with Cdc42 and Rac1
but not with RhoA. In agreement with the lack of binding of RhoA,
INF2 lacks an N-terminal extension to the DID like that present in
the Rho-regulated formins mDia1-2, and that in mDia1 was
found to form part of the RhoC binding site.44 Consistent with
the interaction of INF2 with Cdc42 and Rac1, we have found
that the 2 Rho-family GTPases are necessary for the efficient
transport of Lck to the plasma membrane and appear to function
at different steps in the Lck transport process. Remarkably, the
expression of constitutive-active or dominant-negative forms of
either of these Rho-family GTPases induced the intracellular
accumulation of Lck, mimicking the effect of their individual
silencing. This result indicates that Lck transport requires
dynamic Rac1 and Cdc42 cycling between their GTP- and
guanosine diphosphate-loaded states as proposed for RhoB for
mDia2-mediated endosome movement.39 Similar, one possible
explanation for our findings is that INF2 needs to be, in turn,
dynamically regulated by Rac1 and Cdc42 for Lck transport,
what is consistent with our finding showing the requirement of
actin dynamics for this process.
Silencing of either MAL or INF2 produced the intracellular
accumulation of Lck in pericentriolar endosomes. A similar
effect on Lck distribution has recently been reported in Jurkat
cells knocked down for Uncoordinated 119 protein (Unc119) or
Rab11.45 This study showed that Unc119 binds to Rab11 and
activates its GTPase activity, which, in turn, modulates the
binding of myosin 5B, a key Rab11 effector with the ability to
move along actin filaments and drive endosome movement.46 It
is also worth noting that HIV infection reduces the expression of
Lck at the plasma membrane by causing the intracellular
retention of the molecule by a Nef expression–dependent
mechanism.47 Moreover, the individual expression of Nef
recapitulates the effect of HIV infection on Lck distribution.48
Therefore, there is a remarkable similarity in the overall effect
on Lck distribution of Nef expression and that of INF2, MAL,
Unc119, or Rab11 silencing. The functional integration of all
these proteins in a single pathway for Lck transport would be a
major achievement.
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Although expression of Lck at the plasma membrane is
essential for T-cell function,6 little was known about the
mechanism of Lck targeting. Although other mechanisms might
also coexist,7 our findings in Jurkat cells and primary human
T lymphocytes suggest a mechanism by which Cdc42 and Rac1
control INF2 that, in turn, regulates the formation of MAL-
positive vesicles that transport Lck to the plasma membrane. In
addition to their own importance, our findings could be useful
for investigating the role of MAL in hematologic
malignancies.14-18
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